Skip to main content

Table 1 Clinical characteristics at the beginning of the study

From: Health-related quality of life in T1DM patients after high-dose cholecalciferol supplementation: data from a pilot clinical trial

Clinical characteristics

N = 64

Age (Years)

27.6 ± 10.1

Gender (F/M)

33/31

DM duration (Years)

12.1 ± 8.1

History of dyslipidemia (Yes %)

15 (23.4%)

History of hypertension (Yes %)

10 (15.6%)

History of DKD (Yes %)

20 (31.2%)

History of Diabetic Retinopathy (Yes %)

11 (17.1%)

Smoking (Yes %)

10 (15.6%)

Previous treatment with ACEI/ARB (Yes %)

18 (28.1%)

  1. T1DM type 1 diabetes mellitus, DKD diabetes kidney disease, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, F female, M male